Search Results - "Bjareland, Marcus"

Combining evidence of preferential gene-tissue relationships from multiple sources by Guo, Jing, Hammar, Mårten, Oberg, Lisa, Padmanabhuni, Shanmukha S, Bjäreland, Marcus, Dalevi, Daniel

“…An important challenge in drug discovery and disease prognosis is to predict genes that are preferentially expressed in one or a few tissues, i.e. showing a…”
Get full text

Using the BioAssay Ontology for analyzing high-throughput screening data by Zander Balderud, Linda, Murray, David, Larsson, Niklas, Vempati, Uma, Schürer, Stephan C, Bjäreland, Marcus, Engkvist, Ola

“…High-throughput screening (HTS) is the main starting point for hit identification in drug discovery programs. This has led to a rapid increase of available…”
Get more information

Maintenance goals of agents in a dynamic environment: Formulation and policy construction by Baral, Chitta, Eiter, Thomas, Bjäreland, Marcus, Nakamura, Mutsumi

“…The notion of maintenance often appears in the AI literature in the context of agent behavior and planning. In this paper, we argue that earlier…”
Get full text

SARConnect: A Tool to Interrogate the Connectivity Between Proteins, Chemical Structures and Activity Data by Eriksson, Mats, Nilsson, Ingemar, Kogej, Thierry, Southan, Christopher, Johansson, Martin, Tyrchan, Christian, Muresan, Sorel, Blomberg, Niklas, Bjäreland, Marcus

“…The access and use of large‐scale structure‐activity relationships (SAR) is increasing as the range of targets and availability of bioactive…”
Get full text

Ontology-based interactive information extraction from scientific abstracts by Milward, David, Bjäreland, Marcus, Hayes, William, Maxwell, Michelle, Öberg, Lisa, Tilford, Nick, Thomas, James, Hale, Roger, Knight, Sylvia, Barnes, Julie

“…Over recent years, there has been a growing interest in extracting information automatically or semi‐automatically from the scientific literature. This paper…”
Get full text

Reasoning about action in polynomial time by Drakengren, Thomas, Bjäreland, Marcus

“…Although many formalisms for reasoning about action exist, surprisingly few approaches have taken computational complexity into consideration. The…”
Get full text

Abstract 16571: Over-Optimistic Event Rate Prediction: Frequency and Consequence a Systematic Review of Major Contemporary Cardiovascular Outcome Trials by Andersson, Magnus, Johanson, Per, Bjäreland, Marcus, Hellsten Kronander, Anna, Wei, Jianxin, Karpefors, Martin

“…IntroductionCardiovascular outcome trials (CVOTs) are essential to explore the long term cardiovascular effects of medicines, and since 2008 it is also…”
Get full text

Decision Support in Safety Intelligence Using Pharmaconnect Knowledgebase by Matis, Sherri, Clark, Matt, Bjareland, Marcus, Takasaki, Brian, Mian, Nina, Muresan, Sorel, Popa, Sorona

“…On average it takes approximately 13 years and over 1 billion dollars to take a new medical entity (NME) from a concept to an approved product. As high as 40%…”
Get full text

Execution monitor synthesis for hybrid systems-preliminary report by Bjareland, M.

“…Formal verification methods for hybrid controllers have received a lot of attention during the last decade and so has the problem of synthesizing…”
Get full text